Review of Salvage Therapy for MRSA Bacteremia at Beaumont Health System

Files

Authors

Hazem Alakhras, Beaumont Health Resident
Matthew D. Sims, Beaumont Health
Tracey A.H. Taylor

Description

Treating methicillin-resistant Staphylococcus aureus (MRSA) effectively is imperative to reduce mortality rates, as it contributes to a large amount of healthcare-associated bacteremia in the U.S. However, due to the insufficient and sometimes contradicting studies to guide salvage therapy, there is a lack of clear consensus on treatment of MRSA bacteremia after vancomycin failure. The goal of this study is to showcase the salvage therapies of choice for patients with MRSA bacteremia at Beaumont Health System.

Publication Date

5-2023

Keywords

methicillin-resistant Staphylococcus aureus

Disciplines

Infectious Disease | Internal Medicine

Recommended Citation

Alakhras H, Sims M, Taylor T. Review of salvage therapy for MRSA bacteremia at Beaumont Health System. Poster presented at: Oakland University William Beaumont School of Medicine Embark Capstone Colloquium; 2023 May; Rochester Hills, MI.

Comments

The Embark Capstone Colloquium at the Oakland University William Beaumont School of Medicine, Rochester Hills, MI, May, 2023